© Reuters. FILE PHOTO: Director of the Oxford Vaccine Group Andrew Pollard attends a virtual news conference on the ongoing situation with the coronavirus disease (COVID-19), at Downing Street, London, Britain November 23, 2020. REUTERS/Henry Nicholls/Pool/File Phot
LONDON (Reuters) – Booster shots for COVID-19 vaccines are not currently needed and the doses should be given to other countries, Oxford vaccine chief Andrew Pollard said on Tuesday in contrast to the position taken by Britain’s health minister.
Pollard, who heads the Oxford Vaccine Group, said that a decision to boost should be based on scientific studies, and there had not been any evidence yet of an increase in severe disease or deaths among the fully vaccinated.
“There isn’t any reason at this moment to panic. We’re not seeing a problem with breakthrough severe disease,” he said at an online briefing with lawmakers.
“If there was any falloff in protection, it is something which will happen gradually, and it will be happening at a point where we can pick it up and be able to respond.”
Britain is planning for a COVID-19 vaccine booster programme https://www.reuters.com/world/uk/britain-starts-planning-vaccine-booster-shots-september-2021-06-30, and health minister Sajid Javid said he expected the booster programme to begin in early September, pending final advice from officials.
AstraZeneca (NASDAQ:), which manufactures the vaccine invented at Oxford University, has said it needs more time to assess whether boosters are needed to maintain protection.
That differs from Pfizer (NYSE:), which has said it expects a third shot will be needed to keep protection high.
Britain has given two doses of vaccine to three-quarters of adults, and the World Health Organisation (WHO) https://www.reuters.com/world/europe/french-president-macron-third-covid-vaccine-doses-likely-elderly-vulnerable-2021-08-05 has urged countries that are planning booster programmes to delay them until more people are vaccinated around the world.
Pollard said that vaccine supplies would be better used to protect vulnerable people in other countries.
“Doses that are available that could be used for boosting or for childhood programmes are much better deployed for people who will die over the next six months rather than that very unlikely scenario of a sudden collapse in the programmes in countries that are highly vaccinated,” he said.
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.